TLRY Revenue Flow
Filed revenue amounts for 2025-06-01 to 2026-05-31. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-05-31: Revenue $281.71M*; Revenue including tax (m); Cost of revenue $191.19M*; Research and development $180.00K*.
- 2026-02-28: Revenue $206.73M; Revenue including tax (m); Cost of revenue $151.78M; Research and development $62.00K.
- 2025-11-30: Revenue $217.51M; Revenue including tax (m); Cost of revenue $160.01M; Research and development $78.00K.
- 2025-08-31: Revenue $209.50M; Revenue including tax (m); Cost of revenue $152.03M; Research and development $41.00K.
Ownership
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Geography
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $281.71M* | (m) | $191.19M* | $180.00K* | $106.97M* | $13.86M* | -$49.57M* |
| 2026-02-28 | $206.73M | (m) | $151.78M | $62.00K | $81.34M | $1.97M | -$26.57M |
| 2025-11-30 | $217.51M | (m) | $160.01M | $78.00K | $79.78M | $3.55M | -$44.93M |
| 2025-08-31 | $209.50M | (m) | $152.03M | $41.00K | $55.38M | -$2.29M | -$322.00K |
| 2025-02-28 | $185.78M | (m) | $133.77M | $85.00K | $811.94M | $1.20M | -$789.44M |
| 2024-11-30 | $210.95M | (m) | $149.73M | $60.00K | $103.44M | $2.04M | -$85.34M |
| 2024-08-31 | $200.04M | (m) | $140.34M | $105.00K | $96.28M | $886.00K | -$39.16M |
| 2024-02-29 | $188.34M | (m) | $138.94M | $106.00K | $131.49M | -$2.87M | -$92.70M |
| 2023-11-30 | $193.77M | (m) | $146.36M | $56.00K | $89.17M | -$3.38M | -$49.01M |
| 2023-08-31 | $176.95M | (m) | $132.75M | $79.00K | $78.56M | $7.26M | -$71.53M |
| 2023-02-28 | $145.59M | (m) | $157.29M | $171.00K | $1.20B | -$10.81M | -$1.17B |
| 2022-11-30 | $144.14M | (m) | $101.25M | $165.00K | $94.67M | $11.71M | -$69.46M |
| 2022-08-31 | $153.21M | (m) | $104.60M | $166.00K | $69.79M | $7.21M | -$73.48M |
| 2022-05-31 | (m) | $153.32M* | (m) | (m) | (m) | (m) | (m) |
| 2022-02-28 | $151.87M | $151.87M | $112.04M | $164.00K | $57.91M | -$1.83M | $43.19M |
| 2021-11-30 | $155.15M | $155.15M | $122.39M | $515.00K | $88.30M | -$5.67M | -$201.00K |
| 2021-08-31 | $168.02M | $168.02M | $117.07M | $785.00K | $120.32M | $4.76M | -$41.65M |
| 2021-05-31 | (m) | $142.24M | (m) | (m) | (m) | (m) | $47.20M |
| 2021-03-31 | (m) | $48.02M | $34.52M | $1.20M | (m) | (m) | -$340.95M |
| 2021-02-28 | $123.90M | $123.90M | $93.44M | $127.00K | $54.51M | $6.31M | -$273.52M |
| 2020-12-31 | (m) | $56.56M* | (m) | $1.58M* | (m) | (m) | -$2.95M* |
| 2020-12-30 | (m) | $56.56M | (m) | (m) | (m) | (m) | -$2.95M |
| 2020-11-30 | $129.46M | $129.46M | $94.18M | $225.00K | $61.24M | -$14.19M | -$99.90M |
| 2020-09-30 | (m) | $51.41M | (m) | $921.00K | (m) | (m) | -$2.32M |
| 2020-08-31 | $117.49M | $117.49M | $82.55M | $120.00K | $43.42M | -$5.83M | -$34.34M |
| 2020-06-30 | (m) | $50.41M | (m) | $652.00K | (m) | (m) | -$81.69M |
| 2020-05-31 | (m) | $113.54M | (m) | (m) | (m) | (m) | -$87.11M |
| 2020-03-31 | (m) | $52.10M | $41.23M | $1.35M | (m) | (m) | -$184.12M |
| 2020-02-29 | (m) | $107.74M | (m) | (m) | (m) | (m) | -$11.00M |
| 2019-12-31 | (m) | $46.94M | (m) | (m) | (m) | (m) | -$219.15M |
| 2019-11-30 | (m) | $89.97M | (m) | (m) | (m) | (m) | -$6.00M |
| 2019-09-30 | $51.10M | $51.10M | $35.25M | $2.31M | (m) | (m) | -$36.35M |
| 2019-08-31 | (m) | $94.08M | (m) | (m) | (m) | (m) | $1.56M |
| 2019-06-30 | $45.90M | $45.90M | $33.63M | $1.53M | (m) | (m) | -$36.30M |
| 2019-03-31 | (m) | $23.04M | $17.65M | $1.05M | (m) | (m) | -$29.37M |
| 2018-12-31 | (m) | $15.53M | (m) | (m) | (m) | (m) | -$31.01M |
| 2018-09-30 | $10.05M | $10.05M | $6.98M | $802.00K | (m) | $24.00K | -$18.70M |
| 2018-06-30 | $9.74M | $9.74M | $5.57M | $639.00K | (m) | $63.00K | -$12.83M |
| 2018-03-31 | (m) | $7.81M | $3.91M | $975.00K | (m) | (m) | -$5.18M |
| 2017-12-31 | (m) | $5.11M | (m) | (m) | (m) | (m) | -$2.93M |
| 2017-09-30 | (m) | $5.41M | $2.44M | $729.00K | (m) | $0.00 | -$1.77M |
| 2017-06-30 | (m) | $4.99M | $2.28M | $1.04M | (m) | $0.00 | -$2.44M |
| 2017-03-31 | (m) | $5.03M | (m) | (m) | (m) | (m) | -$679.00K |
Revenue and expense 6 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2025-11-30 | $427.01M | (m) | $312.04M | $119.00K | $135.15M | $1.26M | -$45.25M |
| 2024-11-30 | $410.99M | (m) | $290.07M | $165.00K | $199.71M | $2.92M | -$124.51M |
| 2023-11-30 | $370.72M | (m) | $279.12M | $135.00K | $167.73M | $3.88M | -$120.53M |
| 2022-11-30 | $297.35M | (m) | $205.85M | $331.00K | $164.47M | $4.50M | -$142.94M |
| 2021-11-30 | $323.18M | $323.18M | $239.46M | $1.30M | $208.62M | -$909.00K | -$41.85M |
| 2020-11-30 | $246.95M | $246.95M | $176.72M | $345.00K | $104.66M | -$20.02M | -$134.24M |
| 2020-06-30 | (m) | $102.52M | (m) | $1.91M | (m) | (m) | -$265.81M |
| 2019-06-30 | $68.94M | $68.94M | $51.28M | $2.58M | (m) | (m) | -$65.67M |
| 2018-06-30 | $17.55M | $17.55M | $9.48M | $1.61M | (m) | $63.00K | -$18.01M |
| 2017-06-30 | (m) | $10.02M | $4.56M | $1.70M | (m) | $0.00 | -$3.13M |
Revenue and expense 9 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2026-02-28 | $633.74M | (m) | $463.82M | $181.00K | $216.49M | $3.23M | -$71.83M |
| 2025-02-28 | $596.77M | (m) | $423.84M | $250.00K | $1.01B | $4.13M | -$913.94M |
| 2024-02-29 | $559.06M | (m) | $418.06M | $241.00K | $299.22M | $1.01M | -$213.23M |
| 2023-02-28 | $442.94M | (m) | $363.14M | $502.00K | $1.36B | -$15.31M | -$1.31B |
| 2022-02-28 | $475.05M | $475.05M | $351.50M | $1.46M | $266.53M | -$2.74M | $1.34M |
| 2021-02-28 | $370.85M | $370.85M | $270.17M | $472.00K | $159.17M | -$13.71M | -$407.76M |
| 2020-09-30 | (m) | $153.92M | (m) | $2.83M | (m) | (m) | -$268.12M |
| 2019-09-30 | $120.04M | $120.04M | $86.53M | $4.89M | (m) | (m) | -$102.02M |
| 2018-09-30 | $27.60M | $27.60M | $16.46M | $2.42M | (m) | $87.00K | -$36.71M |
| 2017-09-30 | (m) | $15.43M | $7.00M | $2.43M | (m) | $0.00 | -$4.90M |
Revenue and expense 12 month
| Period end | Revenue | Revenue including tax | Cost of revenue | Research and development | Operating expenses | Income tax | Net income |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $915.45M | (m) | $655.01M | $361.00K | $323.47M | $17.10M | -$121.40M |
| 2025-05-31 | $821.31M | (m) | $580.74M | $284.00K | $2.52B | -$121.02M | -$2.19B |
| 2024-05-31 | $788.94M | (m) | $565.59M | $635.00K | $398.10M | -$26.62M | -$244.98M |
| 2023-05-31 | $627.12M | (m) | $480.16M | $682.00K | $1.52B | -$7.18M | -$1.45B |
| 2022-05-31 | $628.37M | $628.37M | $511.56M | $1.52M | $727.22M | -$6.54M | -$476.80M |
| 2021-05-31 | $513.09M | $513.09M | $389.90M | $830.00K | $255.35M | -$8.97M | -$367.42M |
| 2020-12-31 | (m) | $210.48M | $185.83M | $4.41M | (m) | -$5.60M | -$271.07M |
| 2020-05-31 | $405.33M | $405.33M | $309.27M | $1.92M | $200.06M | -$8.35M | -$102.54M |
| 2019-12-31 | (m) | $166.98M | $190.47M | $9.17M | (m) | -$8.45M | -$321.17M |
| 2019-05-31 | $179.30M | $179.30M | $135.79M | $1.05M | $182.44M | -$2.04M | -$25.04M |
| 2018-12-31 | (m) | $43.13M | $28.86M | $5.86M | (m) | -$4.45M | -$67.72M |
| 2017-12-31 | (m) | $20.54M | $9.16M | $3.17M | (m) | (m) | -$7.81M |
| 2016-12-31 | (m) | $12.64M | $9.97M | $1.14M | (m) | (m) | -$7.88M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |